COL25A1 Antibody (N-term) Blocking Peptide
€363.00
In stock
SKU
AC-BP6964a
Background:
COL25A1 is a brain-specific membrane-bound collagen. Proteolytic processing releases CLAC, a soluble form of COL25A1 containing the extracellular collagen domains that associates with senile plaques in Alzheimer disease.
Other Names:
Collagen alpha-1(XXV) chain, Alzheimer disease amyloid-associated protein, AMY, CLAC-P, Collagen-like Alzheimer amyloid plaque component, CLAC, COL25A1 (HGNC:18603)
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP6964a was selected from the N-term region of human COL25A1. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: COL25A1 (HGNC:18603)
Gene ID: 84570
Primary Accession: Q9BXS0
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
COL25A1 is a brain-specific membrane-bound collagen. Proteolytic processing releases CLAC, a soluble form of COL25A1 containing the extracellular collagen domains that associates with senile plaques in Alzheimer disease.
Other Names:
Collagen alpha-1(XXV) chain, Alzheimer disease amyloid-associated protein, AMY, CLAC-P, Collagen-like Alzheimer amyloid plaque component, CLAC, COL25A1 (HGNC:18603)
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP6964a was selected from the N-term region of human COL25A1. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: COL25A1 (HGNC:18603)
Gene ID: 84570
Primary Accession: Q9BXS0
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
| Is Featured? | No |
|---|
Write Your Own Review